Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study
収録刊行物
-
- The Lancet Respiratory Medicine
-
The Lancet Respiratory Medicine 7 (9), 780-790, 2019-09
Elsevier BV